Shih Yi Lin

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancer

Shih Yi Lin, Ya Y. Wang, Wayne Huey‐Herng Sheu · Clinical Endocrinology · 2003 · 43 citations

Medicine, Oncology, Pathology +16

Increased serum leptin concentrations correlate with soluble tumour necrosis factor receptor levels in patients with cirrhosis

Shih Yi Lin, Ya Yu Wang, Wayne Huey‐Herng Sheu · Clinical Endocrinology · 2002 · 40 citations

Medicine, Endocrinology, Physiology +14

Diagnosis of thyroid metastasis in cancer patients with thyroid mass by fine needle aspiration cytology and ultrasonography.

Shih Yi Lin, Wayne Heuy Herng Sheu, Ming Chen Chang et al. · PubMed · 2002 · 10 citations

Medicine, Oncology, Pathology +17